FROM Steve Scherer
Mixed messages from America's new hard line on Syria Last week, President Trump stunned the world by striking Syria with 59 Tomahawk missiles in retaliation for Bashar al-Assad's use of chemical weapons against his own people. Since then, American diplomats have made contradictory statements in the aftermath of the attack. Was it a "one-off" or is regime change the goal? And why has President Trump retaliated against Syria's use of chemical weapons — but not conventional weapons, which are just as deadly? America's G-7 allies are meeting in Italy to find a consensus for dealing with Syria -- and with Russia — the next stop for America's Secretary of State. Is it too soon for the "political solution" all sides claim to prefer, or will force be used in attempting to remove the Assad regime from power?
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.
What happens when America retreats from the world? Is President Trump taking his "America First" agenda to extremes, withdrawing the country from the international stage on trade and climate change, distancing America from its traditional allies across the Atlantic and even threatening to physically isolate the country through the building of a wall along its southern border? León Krauze guest hosts.